Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Molecular Imaging Homepage

Louisiana getting $14 million Center for Molecular Imaging and Therapy Increasing research opportunities, collaboration and radiopharmaceuticals

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

DOE transfers land to Coquí Pharma for isotope production facility Will be used primarily to produce Mo-99

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

United Imaging's total-body PET scanner shows promise in four new studies Faster scans, lower dose and 'a level of detail never seen in PET'

NorthStar buys IBA electron accelerators for Mo-99 production Will increase production capacity and efficiencies

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Experimental PET tracer finds CTE in former football player: Mt. Sinai researchers

by John W. Mitchell , Senior Correspondent
In an imaging first, researchers at Mount Sinai Hospital in New York have found chronic traumatic encephalopathy (CTE), at the center of the NFL's concussion controversy, on a live, retired player, rather through a postmortem exam after death. The team, which conducted a "proof-of-concept" study, relied on an experimental agent known as Avid 1451.

"This could enable diagnosis during life and could identify potential subjects for anti-CTE drugs that are now being developed," Sam Gandy, M.D., Ph.D., associate director of the Alzheimer's Disease Research Center at Mount Sinai and director of the Center for Cognitive Health and NFL Neurological Care Program at the Icahn School of Medicine at Mount Sinai, told HCB News. "We found a brain scan pattern in a patient with clinical CTE that closely resembled the pattern that pathologists have seen at autopsy."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Avid 1451 has the ability to latch on to tau protein, which can be viewed with PET imaging. He added that the effectiveness of the Avid 1451 study can only be confirmed in any live subject with a postmortem study.

"We will still want to verify that our brain scans match pathology after players with CTE die and come to autopsy. However, many are vigorous young people and that could take a long time to achieve," Gandy explained. "We present this pattern-matching as a possible way to move forward while we are waiting for the autopsies."

The results of the study were recently published in the Journal of Translational Psychiatry.

Reproduced with permission of Translational Psychiatry, the yellow and red splotches may indicate tau protein

The 39-year old player in the study had a history of 22 concussions and exhibited clinical symptoms of CTE. CTE is a neurodegenerative brain disease that has been associated with repetitive blows to the head in athletes and soldiers. The player reported a wide range of symptoms, including: short-term memory loss, headaches, sensitivity to light, irritability, depression, sleep disturbance, delusions, and other symptoms.

According to Gandy, the next step will be to organize a clinical trial of possible CTE treatments once funds are raised for such a study.

CTE has a distinctive pattern of tau protein deposition in the brain. The surface of the brain is highly wrinkled. The tau accumulation in CTE appears to trace the highly-folded surface of the brain and is especially concentrated at the deepest points in the wrinkles and folds.

The NFL has come under increasing scrutiny for the growing evidence of a link between repeated collisions to the head and CTE. Dr. Bennet Omalu, the physician who garnered conclusive proof of the injury, said in a Time magazine article last year that 90 percent of NFL players suffer from CTE. Also, according to a CNN report last year, 10 to 20 percent of Iraqi war veterans also suffer from some form of traumatic brain disorder due to battle concussions.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.